StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) SEC filings

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

SEC filings

4 of Obsidian Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 12, 2026Nov 12, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KJul 31, 2026Aug 3, 2026SEC EDGAR

See a number that looks wrong?